Smith, S. M., Bartlett, N., Johnson, J. L., Cashen, A., Lister, J., Jung, S.-H., … Cheson, B. D. (2010). GALIXIMAB, AN ANTI-CD80 PRIMATIZED MONOCLONAL ANTIBODY, IN RELAPSED HODGKIN LYMPHOMA (HL): FINAL RESULTS OF CALGB 50602. In HAEMATOLOGICA (Vol. 95, pp. S32–S32). FERRATA STORTI FOUNDATION.

Smith, S. M., N. Bartlett, J. L. Johnson, A. Cashen, J. Lister, S. -. H. Jung, H. Schoder, K. Egan, and B. D. Cheson. “GALIXIMAB, AN ANTI-CD80 PRIMATIZED MONOCLONAL ANTIBODY, IN RELAPSED HODGKIN LYMPHOMA (HL): FINAL RESULTS OF CALGB 50602.” In HAEMATOLOGICA, 95:S32–S32. FERRATA STORTI FOUNDATION, 2010.

Smith SM, Bartlett N, Johnson JL, Cashen A, Lister J, Jung S-H, et al. GALIXIMAB, AN ANTI-CD80 PRIMATIZED MONOCLONAL ANTIBODY, IN RELAPSED HODGKIN LYMPHOMA (HL): FINAL RESULTS OF CALGB 50602. In: HAEMATOLOGICA. FERRATA STORTI FOUNDATION; 2010. p. S32–S32.

Smith, S. M., et al. “GALIXIMAB, AN ANTI-CD80 PRIMATIZED MONOCLONAL ANTIBODY, IN RELAPSED HODGKIN LYMPHOMA (HL): FINAL RESULTS OF CALGB 50602.” HAEMATOLOGICA, vol. 95, FERRATA STORTI FOUNDATION, 2010, pp. S32–S32.

Smith SM, Bartlett N, Johnson JL, Cashen A, Lister J, Jung S-H, Schoder H, Egan K, Cheson BD. GALIXIMAB, AN ANTI-CD80 PRIMATIZED MONOCLONAL ANTIBODY, IN RELAPSED HODGKIN LYMPHOMA (HL): FINAL RESULTS OF CALGB 50602. HAEMATOLOGICA. FERRATA STORTI FOUNDATION; 2010. p. S32–S32.